Aripiprazole Tablets I.P.
Shefox (Aripiprazole Tablets I.P.) contains the antipsychotic salt aripiprazole. Unlike many antipsychotics that fully block dopamine, aripiprazole acts as a partial agonist at dopamine D₂ and serotonin 5-HT₁A receptors and as an antagonist at 5-HT₂A receptors. This “stabilizer” profile helps calm overactive pathways that drive hallucinations, delusions, agitation and manic symptoms while supporting pathways that regulate mood, motivation and cognition. The result is control of psychotic and mood symptoms with a generally lower risk of sedation, weight gain and metabolic changes compared with some older agents. Some people may notice akathisia (inner restlessness), nausea, dizziness, insomnia or sleepiness, headache or anxiety these are usually mild and improve as dosing is optimized.
Shefox (aripiprazole) is used under medical supervision for schizophrenia and bipolar I disorder (manic or mixed episodes, and maintenance). Where clinically appropriate and permitted by local guidance, it may also be used as adjunct therapy for major depressive disorder (MDD) to boost antidepressant response, and for irritability associated with autism spectrum disorder.